Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2023. Start Trial.
Date Value
November 18, 2026 6.812B
November 17, 2026 7.183B
November 16, 2026 7.468B
November 13, 2026 9.429B
November 12, 2026 9.760B
November 11, 2026 10.49B
November 10, 2026 10.49B
November 09, 2026 10.49B
November 06, 2026 9.792B
November 05, 2026 9.507B
November 04, 2026 9.608B
November 03, 2026 9.158B
November 02, 2026 9.388B
October 30, 2026 10.08B
October 29, 2026 10.08B
October 28, 2026 9.715B
October 27, 2026 9.618B
October 26, 2026 9.847B
October 23, 2026 9.939B
October 22, 2026 9.930B
October 21, 2026 11.12B
October 20, 2026 11.12B
October 19, 2026 10.52B
October 16, 2026 10.31B
October 15, 2026 10.31B
Date Value
October 14, 2026 11.00B
October 13, 2026 12.05B
October 12, 2026 13.33B
October 09, 2026 13.33B
October 08, 2026 12.65B
October 07, 2026 12.65B
October 06, 2026 12.60B
October 05, 2026 12.60B
October 02, 2026 12.32B
October 01, 2026 12.43B
September 30, 2026 12.18B
September 29, 2026 11.91B
September 28, 2026 11.55B
September 25, 2026 11.55B
September 24, 2026 11.45B
September 23, 2026 10.86B
September 22, 2026 11.32B
September 21, 2026 11.57B
September 18, 2026 10.52B
September 17, 2026 10.47B
September 16, 2026 10.78B
September 15, 2026 11.24B
September 14, 2026 11.32B
September 11, 2026 10.81B
September 10, 2026 11.40B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Ascletis Pharma, Inc. 567.37M
CStone Pharmaceuticals Co. Ltd. 966.82M
RemeGen Co., Ltd. 4.804B
InnoCare Pharma Ltd. 2.178B
Adagene, Inc. 209.48M

Enterprise Value Related Metrics